Ramaswamy Vivek bought ROIV
December 12, 2025 · Form 4 insider transaction
Ramaswamy Vivek bought 4,672,724 shares of Roivant Sciences Ltd. at $12.68 per share, a transaction worth $59.25M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
4,672,724
Price
$12.68
Total value
$59.25M
InsiderRamaswamy Vivek
Role—
CompanyRoivant Sciences Ltd. (ROIV)
SecurityCommon Shares
Transaction codeM: Option exercise
Transaction dateDecember 12, 2025
Filing dateDecember 15, 2025
Shares owned after38,326,479
OwnershipDirect
10b5-1 planNo
AmendedNo